Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs).
Authors
Darren Cowzer
Memorial Sloan Kettering Cancer Center, New York, NY;
Darren Cowzer , Ronak H. Shah , Sippy Punn , Laura Fiedler , April DeMore , Joanne F. Chou , Marinela Capanu , Michael F. Berger , Diane Reidy-Lagunes , Nitya Prabhakar Raj
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 653)
DOI
10.1200/JCO.2023.41.4_suppl.653
Abstract #
653
Poster Bd #
H3
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT.
First Author: Nitya Prabhakar Raj
Poster
2018 Gastrointestinal Cancers Symposium
Utility of comprehensive genomic profiling (CGP) to distinguish neoplasms pathologically diagnosed as PanNETs and PanNECs and identify potentially actionable genomic alterations (GA).
First Author: Aatur D. Singhi
Poster
2022 ASCO Annual Meeting
Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC).
First Author: Darren Cowzer
Poster
2021 ASCO Annual Meeting
Cell-free circulating tumor DNA (cfDNA) analysis of advanced thymic epithelial tumors (TETs).
First Author: Hiba I. Dada